RSS-Feed abonnieren

DOI: 10.1055/s-0045-1805075
Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review

Abstract
The etiology of Parkinson's disease (PD) is complex and multifactorial, depending on interactions involving environmental/lifestyle and genetic factors. The genetic aspects of the disease are becoming well characterized, while the environmental factors still need further investigation. In the present narrative review, we have described the most concrete evidence of associations between environmental factors and the risk of developing PD. Physical activity, healthy dietary patterns, smoking, and caffeine intake are protective factors against PD. Head trauma, consumption of milk and dairy products, and pesticide exposure were associated with a higher risk of developing PD. The associations of alcohol consumption, living in rural areas, farming, and consumption of well water with PD are still controversial. Results of several studies strongly suggest that diabetes mellitus is a risk factor for the development of PD, as well as the pre-diabetic state. Lower serum levels of uric acid were associated with an increased risk of developing PD and with worse clinical features and faster progression of symptoms. The protective effects of nonsteroidal antiinflammatory drugs use are controversial. Several other factors were potentially associated with the risk of developing PD: environmental pollutants such as organic solvents, exposure to sunlight, vitamin D deficiency, bullous pemphigoid, bipolar disorder, inflammatory bowel disease, irritable bowel syndrome, certain infections and agents, and essential tremor. Environmental factors are important risk markers for the development of PD. Understanding these risks and protective factors could lead to the implementation of risk-modifying actions for PD.
Authors' Contributions
VT: conceptualization, data curation, formal analysis, investigation, methodology, project administration, supervision, validation, resources, visualization, writing – original draft, and writing – review & editing; AFSS, ALZR, BLSL, CRMR, DHN, DJS, ERB, GHL, HBF, IFM, MVDC, PBN, RGC, and VB: conceptualization, data curation, formal analysis, investigation, methodology, project administration, supervision, validation, writing – original draft, and writing – review & editing; and MJA, MCS, DLB, CCS, MCC, AVC, LRM, COV, ABFG, CGMC, FECC, and STC: investigation, writing – original draft, and writing – review & editing.
Editor-in-Chief: Hélio A. G. Teive.
Associate Editor: Renato Puppi Munhoz.
Publikationsverlauf
Eingereicht: 16. September 2024
Angenommen: 26. November 2024
Artikel online veröffentlicht:
19. März 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Vitor Tumas, Marcelo Jhonatan Aureliano, Carlos Roberto de Melo Rieder, Artur Francisco Schumacher Schuh, Henrique Ballalai Ferraz, Vanderci Borges, Maria Carolina Soares, Dayany Leonel Boone, Carolina Candeias da Silva, Mariana Cavalcanti Costa, Delson José da Silva, Aracelle Victor do Carmo, Luana de Rezende Mikael, Bruno Lopes Santos-Lobato, Ana Lucia Zuma Rosso, Celmir de Oliveira Vilaça, Pedro Braga-Neto, André Borges Ferreira Gomes, Camila Gonçalves Monteiro Carvalho, Grace Helena Letro, Denise Hack Nicaretta, Marcus Vinicius Della Coletta, Egberto Reis Barbosa, Rubens Gisbert Cury, Francisco Eduardo Costa Cardoso, Sarah Teixeira Camargos, Ignacio Fernandez Mata. Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review. Arq Neuropsiquiatr 2025; 83: s00451805075.
DOI: 10.1055/s-0045-1805075
-
References
- 1 Duvoisin RC. Etiology of Parkinson's disease: current concepts. Clin Neuropharmacol 1986; 9 (Suppl. 01) S3-S21
- 2 Nalls MA, Blauwendraat C, Vallerga CL. et al; 23andMe Research Team, System Genomics of Parkinson's Disease Consortium, International Parkinson's Disease Genomics Consortium. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol 2019; 18 (12) 1091-1102
- 3 Dorsey ER, Sherer T, Okun MS, Bloem BR. The Emerging Evidence of the Parkinson Pandemic. J Parkinsons Dis 2018; 8 (s1): S3-S8
- 4 Fang X, Han D, Cheng Q. et al. Association of Levels of Physical Activity With Risk of Parkinson Disease: A Systematic Review and Meta-analysis. JAMA Netw Open 2018; 1 (05) e182421
- 5 Langeskov-Christensen M, Franzén E, Grøndahl Hvid L, Dalgas U. Exercise as medicine in Parkinson's disease. J Neurol Neurosurg Psychiatry 2024; 95 (11) 1077-1088
- 6 Chen Y, Sun X, Lin Y, Zhang Z, Gao Y, Wu IXY. Non-Genetic Risk Factors for Parkinson's Disease: An Overview of 46 Systematic Reviews. J Parkinsons Dis 2021; 11 (03) 919-935
- 7 Larsson SC, Burgess S. Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies. EBioMedicine 2022; 82: 104154
- 8 Li X, Li W, Liu G, Shen X, Tang Y. Association between cigarette smoking and Parkinson's disease: A meta-analysis. Arch Gerontol Geriatr 2015; 61 (03) 510-516
- 9 Mappin-Kasirer B, Pan H, Lewington S. et al. Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors. Neurology 2020; 94 (20) e2132-e2138
- 10 Ma C, Liu Y, Neumann S, Gao X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl Neurodegener 2017; 6: 18
- 11 Oertel WH, Müller HH, Unger MM. et al. Transdermal Nicotine Treatment and Progression of Early Parkinson's Disease. NEJM Evid 2023; 2 (09) a2200311
- 12 Palacios N, Gao X, McCullough ML. et al. Caffeine and risk of Parkinson's disease in a large cohort of men and women. Mov Disord 2012; 27 (10) 1276-1282
- 13 Tanaka K, Miyake Y, Fukushima W. et al; Fukuoka Kinki Parkinson's Disease Study Group. Intake of Japanese and Chinese teas reduces risk of Parkinson's disease. Parkinsonism Relat Disord 2011; 17 (06) 446-450
- 14 Medeiros MS, Schumacher-Schuh AF, Altmann V, Rieder CRM. A Case-Control Study of the Effects of Chimarrão (Ilex paraguariensis) and Coffee on Parkinson's Disease. Front Neurol 2021; 12: 619535
- 15 Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A. Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. J Alzheimers Dis 2010; 20 (Suppl. 01) S221-S238
- 16 Gigante AF, Asabella AN, Iliceto G. et al. Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease. Neurol Sci 2018; 39 (03) 551-555
- 17 Chuang YH, Lill CM, Lee PC. et al. Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2. Neuroepidemiology 2016; 47 (3-4): 192-200
- 18 Rivera-Oliver M, Díaz-Ríos M. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. Life Sci 2014; 101 (1-2): 1-9
- 19 Postuma RB, Anang J, Pelletier A. et al. Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial. Neurology 2017; 89 (17) 1795-1803
- 20 Gao X, Chen H, Fung TT. et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 2007; 86 (05) 1486-1494
- 21 Liu YH, Jensen GL, Na M. et al. Diet Quality and Risk of Parkinson's Disease: A Prospective Study and Meta-Analysis. J Parkinsons Dis 2021; 11 (01) 337-347
- 22 Strikwerda AJ, Dommershuijsen LJ, Ikram MK, Voortman T. Diet Quality and Risk of Parkinson's Disease: The Rotterdam Study. Nutrients 2021; 13 (11) 3970
- 23 Tresserra-Rimbau A, Thompson AS, Bondonno N, Jennings A, Kühn T, Cassidy A. Plant-Based Dietary Patterns and Parkinson's Disease: A Prospective Analysis of the UK Biobank. Mov Disord 2023; 38 (11) 1994-2004
- 24 Haas J, Berg D, Bosy-Westphal A, Schaeffer E. Parkinson's Disease and Sugar Intake-Reasons for and Consequences of a Still Unclear Craving. Nutrients 2022; 14 (15) 3240
- 25 Jafari S, Etminan M, Aminzadeh F, Samii A. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord 2013; 28 (09) 1222-1229
- 26 Taylor KM, Saint-Hilaire MH, Sudarsky L. et al. Head injury at early ages is associated with risk of Parkinson's disease. Parkinsonism Relat Disord 2016; 23: 57-61
- 27 Talebi S, Asoudeh F, Naeini F, Sadeghi E, Travica N, Mohammadi H. Association between animal protein sources and risk of neurodegenerative diseases: a systematic review and dose-response meta-analysis. Nutr Rev 2023; 81 (09) 1131-1143
- 28 Hughes KC, Gao X, Kim IY. et al. Intake of dairy foods and risk of Parkinson disease. Neurology 2017; 89 (01) 46-52
- 29 Zhang Z, Wang M, Yuan S, Larsson SC, Liu X. Genetically Predicted Milk Intake and Risk of Neurodegenerative Diseases. Nutrients 2021; 13 (08) 2893
- 30 Melnik BC. Synergistic Effects of Milk-Derived Exosomes and Galactose on α-Synuclein Pathology in Parkinson's Disease and Type 2 Diabetes Mellitus. Int J Mol Sci 2021; 22 (03) 1059
- 31 FAO. Pesticides use and trade, 1990–2021, in FAOSTAT Analytical Briefs Series 2022, FAO: Rome, Italy.
- 32 Kulcsarova K, Bang C, Berg D, Schaeffer E. Pesticides and the Microbiome-Gut-Brain Axis: Convergent Pathways in the Pathogenesis of Parkinson's Disease. J Parkinsons Dis 2023; 13 (07) 1079-1106
- 33 Ahmed H, Abushouk AI, Gabr M, Negida A, Abdel-Daim MM. Parkinson's disease and pesticides: A meta-analysis of disease connection and genetic alterations. Biomed Pharmacother 2017; 90: 638-649
- 34 Ferraz HB, Bertolucci PH, Pereira JS, Lima JG, Andrade LA. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 1988; 38 (04) 550-553
- 35 Bloem BR, Boonstra TA. The inadequacy of current pesticide regulations for protecting brain health: the case of glyphosate and Parkinson's disease. Lancet Planet Health 2023; 7 (12) e948-e949
- 36 Ibama, Painéis de informações de agrotóxicos. 2023, Ibama: Brazil.
- 37 FAO. W.a., Guidance on good labelling practice for pesticides (Second revision) in International Code of Conduct on Pesticide Management. 2022, FAO and WHO: Rome, Italy.
- 38 Narayan S, Liew Z, Paul K. et al. Household organophosphorus pesticide use and Parkinson's disease. Int J Epidemiol 2013; 42 (05) 1476-1485
- 39 Moura DD, Borges V, Ferraz HB. et al. History of high household pesticide use and Parkinson's disease in Brazil. Parkinsonism Relat Disord 2023; 113: 105493
- 40 Santos-Lobato BL. Towards a methodological uniformization of environmental risk studies in Parkinson's disease. NPJ Parkinsons Dis 2024; 10 (01) 86
- 41 Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Alcohol consumption and risk for Parkinson's disease: a systematic review and meta-analysis. J Neurol 2019; 266 (08) 1821-1834
- 42 Mitchell E, Chohan H, Bestwick JP, Noyce AJ. Alcohol and Parkinson's Disease: A Systematic Review and Meta-Analysis. J Parkinsons Dis 2022; 12 (08) 2369-2381
- 43 Peters S, Gallo V, Vineis P. et al. Alcohol Consumption and Risk of Parkinson's Disease: Data From a Large Prospective European Cohort. Mov Disord 2020; 35 (07) 1258-1263
- 44 Veronese N, Nova A, Fazia T. et al. Contribution of Nutritional, Lifestyle, and Metabolic Risk Factors to Parkinson's Disease. Mov Disord 2024; 39 (07) 1203-1212
- 45 Domínguez-Baleón C, Ong JS, Scherzer CR, Rentería ME, Dong X. Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study. Sci Rep 2021; 11 (01) 13980
- 46 Li M, Zhang X, Chen K. et al. Alcohol Exposure and Disease Associations: A Mendelian Randomization and Meta-Analysis on Weekly Consumption and Problematic Drinking. Nutrients 2024; 16 (10) 1517
- 47 Barbeau A, Roy M, Bernier G, Campanella G, Paris S. Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas. Can J Neurol Sci 1987; 14 (01) 36-41
- 48 Breckenridge CB, Berry C, Chang ET, Sielken Jr RL, Mandel JS. Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis. PLoS One 2016; 11 (04) e0151841
- 49 Walker RW, Hand A, Jones C, Wood BH, Gray WK. The prevalence of Parkinson's disease in a rural area of North-East England. Parkinsonism Relat Disord 2010; 16 (09) 572-575
- 50 Chen CC, Chen TF, Hwang YC. et al. Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan. Neuroepidemiology 2009; 33 (04) 350-357
- 51 Fealy S, Logan PA, Micalos PS. et al. Exploring Parkinson's disease prevalence in regional, rural and remote Australia: A systematic scoping review. Aust J Rural Health 2023; 31 (06) 1156-1167
- 52 Ayton D, Ayton S, Barker AL, Bush AI, Warren N. Parkinson's disease prevalence and the association with rurality and agricultural determinants. Parkinsonism Relat Disord 2019; 61: 198-202
- 53 Kab S, Spinosi J, Chaperon L. et al. Agricultural activities and the incidence of Parkinson's disease in the general French population. Eur J Epidemiol 2017; 32 (03) 203-216
- 54 Jin X, Lu Y, Gong Z, Huang W, Wang Z. Prediabetes and the incidence of Parkinson's disease: A meta-analysis. Biomol Biomed 2024; 24 (04) 722-730
- 55 Chohan H, Senkevich K, Patel RK. et al. Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression. Mov Disord 2021; 36 (06) 1420-1429
- 56 Athauda D, Evans J, Wernick A. et al. The Impact of Type 2 Diabetes in Parkinson's Disease. Mov Disord 2022; 37 (08) 1612-1623
- 57 Xie Y, Wang J, Jiang J, Liu F, Zhang Y. Do oral antidiabetic medications alter the risk of Parkinson's disease? An updated systematic review and meta-analysis. Neurol Sci 2023; 44 (12) 4193-4203
- 58 Athauda D, Maclagan K, Skene SS. et al. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet 2017; 390 (10103): 1664-1675
- 59 Meissner WG, Remy P, Giordana C. et al; LIXIPARK Study Group. Trial of Lixisenatide in Early Parkinson's Disease. N Engl J Med 2024; 390 (13) 1176-1185
- 60 Grażyńska A, Adamczewska K, Antoniuk S. et al. The Influence of Serum Uric Acid Level on Non-Motor Symptoms Occurrence and Severity in Patients with Idiopathic Parkinson's Disease and Atypical Parkinsonisms-A Systematic Review. Medicina (Kaunas) 2021; 57 (09) 972
- 61 Wen M, Zhou B, Chen YH. et al. Serum uric acid levels in patients with Parkinson's disease: A meta-analysis. PLoS One 2017; 12 (03) e0173731
- 62 Shen C, Guo Y, Luo W, Lin C, Ding M. Serum urate and the risk of Parkinson's disease: results from a meta-analysis. Can J Neurol Sci 2013; 40 (01) 73-79
- 63 Koros C, Simitsi AM, Papagiannakis N. et al. Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson's Disease: Longitudinal Data from the PPMI Study. J Parkinsons Dis 2023; 13 (05) 811-818
- 64 Fazlollahi A, Zahmatyar M, Alizadeh H. et al. Association between gout and the development of Parkinson's disease: a systematic review and meta-analysis. BMC Neurol 2022; 22 (01) 383
- 65 Seifar F, Dinasarapu AR, Jinnah HA. Uric Acid in Parkinson's Disease: What Is the Connection?. Mov Disord 2022; 37 (11) 2173-2183
- 66 Sheng YL, Chen X, Hou XO. et al. Urate promotes SNCA/α-synuclein clearance via regulating mTOR-dependent macroautophagy. Exp Neurol 2017; 297: 138-147
- 67 Schwarzschild MA, Ascherio A, Casaceli C. et al; Parkinson Study Group SURE-PD3 Investigators. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA 2021; 326 (10) 926-939
- 68 Chen H, Zhang SM, Hernán MA. et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 2003; 60 (08) 1059-1064
- 69 Bornebroek M, de Lau LM, Haag MD. et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Neuroepidemiology 2007; 28 (04) 193-196
- 70 Poly TN, Islam MMR, Yang HC, Li YJ. Non-steroidal anti-inflammatory drugs and risk of Parkinson's disease in the elderly population: a meta-analysis. Eur J Clin Pharmacol 2019; 75 (01) 99-108
- 71 Ren L, Yi J, Yang J, Li P, Cheng X, Mao P. Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease: A dose-response meta-analysis. Medicine (Baltimore) 2018; 97 (37) e12172
- 72 Xie Z, Zhou H, Qiu Z. et al. Association between 23 drugs and Parkinson's disease: A two-sample Mendelian randomization study. Brain Behav 2023; 13 (11) e3225
- 73 Lai YC, Yew YW, Lambert WC. Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2016; 30 (12) 2007-2015
- 74 Faustino PR, Duarte GS, Chendo I. et al. Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis. JAMA Neurol 2020; 77 (02) 192-198
- 75 Schrag A, Bohlken J, Dammertz L. et al. Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease. JAMA Neurol 2023; 80 (02) 161-171
- 76 Zong J, Yang Y, Wang H, Zhang H, Yang X, Yang X. The two-directional prospective association between inflammatory bowel disease and neurodegenerative disorders: a systematic review and meta-analysis based on longitudinal studies. Front Immunol 2024; 15: 1325908
- 77 Lu S, Jiang HY, Shi YD. Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta-analysis. Acta Neurol Scand 2022; 145 (04) 442-448
- 78 Breen DP, Halliday GM, Lang AE. Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?. Mov Disord 2019; 34 (03) 307-316
- 79 Nielsen SS, Warden MN, Sallmén M. et al. Solvent exposed occupations and risk of Parkinson disease in Finland. Clin Park Relat Disord 2021; 4: 100092
- 80 Vlaar T, Kab S, Schwaab Y, Fréry N, Elbaz A, Moisan F. Association of Parkinson's disease with industry sectors: a French nationwide incidence study. Eur J Epidemiol 2018; 33 (11) 1101-1111
- 81 Goldman SM, Weaver FM, Stroupe KT. et al; Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune. Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune. JAMA Neurol 2023; 80 (07) 673-681
- 82 Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB. MDS Task Force on the Definition of Parkinson's Disease. Update of the MDS research criteria for prodromal Parkinson's disease. Mov Disord 2019; 34 (10) 1464-1470